Human Technopole takes part in the Milano Digital Week
This year Human Technopole, took part in Milano Digital Week, which in this edition was held in virtual mode on the event’s website.
Francesco Iorio, Group Leader of the Centre for Computational Biology, gave a keynote speech entitled “Genomic editing and big data for precision medicine in oncology“.
Francesco Iorio’s intervention starts from estimated numbers- in the course of one’s life, 1 out of 2 people will develop some form of cancer – and from the observation that, unfortunately, at the moment, there are still too few targeted drugs capable of defusing the vital mechanisms of cancer, attacking it selectively and without causing severe side effects.
Recently, new frontiers for personalised medicine are opening up thanks to
advances in genomic editing, big data of various kinds – biomedical and non biomedical and genomic – and the reduction of molecular profiling costs. These aspects are allowing scientists to make great steps in the discovery of new therapeutic targets and related molecular markers for predicting therapeutic response in patients. We are therefore witnessing a paradigm shift in the development of new anti-cancer drugs, which promises enormous benefits for cancer patients and their quality of life.
Watch the video here.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.